Which statement correctly reflects the role of the FDA regarding drug names?

The statement indicating that the FDA does not sponsor USAN is correct because the United States Adopted Names (USAN) Council is responsible for the selection and promotion of nonproprietary drug names. While the FDA plays a critical role in regulating drugs and ensuring their safety and efficacy, it does not directly sponsor or control the naming process carried out by the USAN Council. Instead, the FDA reviews proposed drug names to avoid confusion among similar-sounding names and to ensure they are not misleading, but it does not itself create or endorse the names.

This differentiation highlights the FDA’s regulatory functions versus the naming conventions managed by a separate entity, illustrating the structured collaboration in the pharmaceuticals industry.